Toggle Main Menu Toggle Search

Open Access padlockePrints

Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: Potential interactions in gene regulation

Lookup NU author(s): Dr Neil Hanley, Dr David Wilson, Dr Stephen Ball


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Cytochrome P450 17α-hydroxylase/17-20 lyase (P450C17) is a critical branchpoint enzyme for steroid hormone biosynthesis. During human gestation, P450C17 is required for the production of dehydroepiandrostenedione sulfate by the fetal adrenal cortex and for testicular production of androgens that mediate male sexual differentiation. In this study, we investigate the regulation of the human CYP17 gene by two orphan nuclear receptors, steroidogenic factor 1 (SF-1) and DAX1. In human embryos, SF-1 and DAX1 are expressed throughout the developing adrenal cortex from its inception at 33 days post conception (dpc). In contrast, P450C17 expression, which commences between 41 and 44 dpc, is limited to the fetal zone. The 5́-flanking region of the human CYP17 gene contains three functional SF-1 elements that collectively mediate a ≥25-fold induction of promoter activity by SF-1. In constructs containing all three functional SF-1 elements, DAX1 inhibited this activation by ≥55%. In the presence of only one or two SF-1 elements, DAX1 inhibition was lost even though SF-1 transactivation persisted. These data suggest that efficient repression of SF-1-mediated activation of the human CYP17 gene by DAX1 requires multiple SF-1 elements. Opposing effects of SF-1 and DAX1 may fine tune the differential responses of various SF-1 target genes in different endocrine tissues.

Publication metadata

Author(s): Ball SG; Hanley NA; Wilson DI; Rainey WE; Parker KL

Publication type: Article

Publication status: Published

Journal: Molecular Endocrinology

Year: 2001

Volume: 15

Issue: 1

Pages: 57-68

Print publication date: 01/01/2001

ISSN (print): 0888-8809

ISSN (electronic): 1944-9917

Publisher: The Endocrine Society


DOI: 10.1210/me.15.1.57

PubMed id: 11145739


Altmetrics provided by Altmetric


Funder referenceFunder name
G9826762Medical Research Council